These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 9490080

  • 1. Synthesis, preliminary evaluation and molecular modeling studies of new, conformationally constrained analogues of the competitive NMDA receptor antagonist 4-(phosphonomethyl)-2-piperidinecarboxylic acid (CGS 19755).
    Pellicciari R, Marinozzi M, Natalini B, Costantino G, Lankin DC, Snyder JP, Monahan JB.
    Farmaco; 1997; 52(6-7):477-86. PubMed ID: 9490080
    [Abstract] [Full Text] [Related]

  • 2. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM, Jane DE, Monaghan DT.
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
    [Abstract] [Full Text] [Related]

  • 3. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
    Okada M, Ueda H, Kometani M, Nakao K.
    Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis of conformationally constrained glutamic acid homologues and investigation of their pharmacological profiles.
    Conti P, Pinto A, Tamborini L, Grazioso G, De Sarro G, Bräuner-Osborne H, Szabo G, Gábor Hársing L, De Micheli C.
    ChemMedChem; 2007 Nov; 2(11):1639-47. PubMed ID: 17849399
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Syntheses, activity and modeling studies of 3- and 4-(sulfo- and sulfonamidoalkyl)pyridine and piperidine-2-carboxylic acid derivatives as analogs of NMDA receptor antagonists.
    el Hadri A, Maldivi P, Leclerc G, Rocher JP.
    Bioorg Med Chem; 1995 Sep; 3(9):1183-201. PubMed ID: 8564410
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.
    Calabri FR, Colotta V, Catarzi D, Varano F, Lenzi O, Filacchioni G, Costagli C, Galli A.
    Eur J Med Chem; 2005 Sep; 40(9):897-907. PubMed ID: 15919134
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers.
    Takayama H, Yaegashi Y, Kitajima M, Han X, Nishimura K, Okuyama S, Igarashi K.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4729-32. PubMed ID: 17624774
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.
    Allen RM, Carelli RM, Dykstra LA, Suchey TL, Everett CV.
    J Pharmacol Exp Ther; 2005 Oct 01; 315(1):449-57. PubMed ID: 16024734
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
    Conti P, De Amici M, Joppolo Di Ventimiglia S, Stensbøl TB, Madsen U, Bräuner-Osborne H, Russo E, De Sarro G, Bruno G, De Micheli C.
    J Med Chem; 2003 Jul 03; 46(14):3102-8. PubMed ID: 12825948
    [Abstract] [Full Text] [Related]

  • 18. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
    Kew JN, Trube G, Kemp JA.
    Br J Pharmacol; 1998 Feb 03; 123(3):463-72. PubMed ID: 9504387
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.